Because it acts as an antagonist at the AMPA, Kainate, and NMDA receptors, L-theanine directly blocks the binding of excess glutamate
Indeed, several studies have shown that the loss of body mass induced by GLP-1 analogues was 5.8 to 17.3%, over a duration of 56 to 72 weeks, compared to a placebo
Hepatol Int 19 , 337348 (2025)
As of early 2026, the global success of existing treatments has paved the way for a second generation of Glucagon-Like Peptide-1 (GLP-1) receptor agonists currently in Phase-3 trials
Just days after the reforms passed, U.S
That study demonstrated that constructing pathway-based comorbidity networks using high-centrality (hub) pathways can uncover key molecular interactions that may be overlooked by traditional transcriptomic analyses, particularly in the absence of human comorbid datasets